| 09.04.2021 |
What should be considered in case of a positive allergy history before a vaccination against COVID-19? |
| 08.04.2021 |
COVID-19 Vaccine Vaxzevria (AstraZeneca) - Possible Link with Very Rare Cases of Unusual Blood Clots in Combination with Lowered Platelet Counts |
| 08.04.2021 |
Bulletin on Drug Safety - Current Issue 1/2021 Published |
| 29.03.2021 |
CHMP starts Rolling Review for the first Virus-like Particle Vaccine against COVID-19 |
| 22.03.2021 |
Occurrence of Cerebral Venous Thrombosis after Vaccination with COVID-19 Vaccine AstraZeneca |
| 08.04.2021 |
COVID-19 Vaccine AstraZeneca – Safety Assessment Result: The Vaccine is Safe and Effective in the Fight against COVID-19 |
| 16.03.2021 |
The Paul-Ehrlich-Institut informs - Temporary Suspension of Vaccination with COVID-19 Vaccine AstraZeneca |
| 11.03.2021 |
Committee for Medicinal Products for Human Use (CHMP) Recommends Conditional Marketing Authorisation of the COVID-19 Vaccine by Janssen-Cilag International N.V. |
| 11.03.2021 |
Monoclonal Antibody Cocktails against COVID-19 in Rolling Review |
| 11.03.2021 |
European Commission Grants Conditional Marketing Authorisation for COVID-19 Vaccine by Janssen-Cilag N.V. for the European Union |
| 11.03.2021 |
COVID-19 Vaccine AstraZeneca |
| 04.03.2021 |
Rolling Review Procedure started for the COVID-19 Vaccine Candidate Sputnik V from Russia at the European Medicines Agency |
| 01.03.2021 |
Regulatory Response to SARS-CoV-2 Mutations |
| 23.02.2021 |
2-day Workshop – GMP-compliant Manufacturing of COVID-19 Vaccines |
| 22.02.2021 |
Pneumococcal Vaccine Pneumovax 23 imported with Chinese Presentation |
| 22.02.2021 |
Janssen-Cilag International N.V. applies for a Conditional Marketing Authorisation of its COVID-19 Vaccine |
| 22.02.2021 |
Invitation to Apply for the Langen Science Award 2021 |
| 18.02.2021 |
Safety and Efficacy of the COVID-19 Vaccine AstraZeneca |
| 18.02.2021 |
Spring Symposium - LOEWE Center DRUID |
| 17.02.2021 |
European Medicines Agency (EMA) has started Fourth Rolling Review of a COVID-19 Vaccine Candidate for Europe |
| 08.02.2021 |
T2EVOLVE: Alliance for Rapid Advancement in Cancer Therapy |
| 03.02.2021 |
Dialogue – Performance Profile of the Paul-Ehrlich-Institut advanced during the Pandemic |
| 29.01.2021 |
European Commission grants conditional marketing authorisation for COVID-19 Vaccine Astra Zeneca for the European Union |
| 29.01.2021 |
Committee for Medicinal Products for Human Use Recommends Conditional Marketing Authorisation for the COVID-19 Vaccine from AstraZeneca |
| 22.01.2021 |
Online Reporting Portal pursuant to the German Transplantation Act is now ready to operate |
| 21.01.2021 |
New Coordinator for the Working Parties of the DGfI |
| 18.01.2021 |
EMA receives Application for Conditional Marketing Authorisation of COVID-19 Vaccine of AstraZeneca |
| 06.01.2021 |
EMA’s Committee for Medicinal Products for Human Use recommends Conditional Marketing Authorisation for Moderna’s COVID-19 Vaccine |
| 06.01.2021 |
European Commission Grants Marketing Authorisation for COVID-19 Vaccine from Moderna for the European Union |
